Understand company pipelines for cancer products
(PRWEB) November 30, 2004 -- Piribo, (http://www.piribo.com) the online destination for business intelligence for the biopharma industry, has added the report Pipeline Insight: Cancer Overview - Numerous Diverse Drugs Approaching Fruition” to its collection.
The report reviews 10 tumor types which will account for two million new cases and one million deaths in 2004 in the seven major pharmaceutical markets, accounting for 60% of all cancers.
Advances in tumor understanding have initiated major R&D changes, with a resulting shift towards targeted therapies, which make up 64% of the current pipeline. As specific tumor pathways are targeted, fragmentation of the oncology market will occur as patient differentiation becomes based on malignant growth drivers rather than primary tumor site.
Future cancer treatment will employ a multidisciplinary approach, incorporating the forthcoming influx of targeted therapies into current standard regimens. The cytotoxics and anti-hormonals markets will become increasingly genericized, however costs will increase with incorporation of targeted therapies.
The 'big four' tumor types (breast, prostate, non-small cell lung, colorectal) will remain the focus of R&D due to their high incidence, unmet needs and commercial potential. However, companies investing in new pancreatic cancer agents will see substantial benefits if an effective agent is developed, due to the current high level of unmet need.
Key reasons to read this report:
- Identify key drugs and companies within the oncology pipeline based on sales forecast to 2012
- Characterize unmet need and poorly served markets within oncology and assess the potential for pipeline agents to provide satisfaction
- Assess the shifting oncology market dynamic and how future treatment and management of cancer patients will be affected
Table of Contents:
- Key Findings
- Cancer Patient Potential
- R&D Approach
- Oncology Pipeline Analysis
- Oncology Drug Analysis & Forecasts
- Oncology Commonalities
Information about the report can be found at:
http://www.piribo.com/publications/diseases_conditions/cancer/pipeline_cancer.html
# # #
|
